Patent · US Active

Proton-binding polymers for oral administration

US11311571B2 · kind B2 · utility

3Cited by

45References

11Claims

0Family size

Assignee

TRICIDA, INC. · US

Inventors

Gerrit Klaerner · Los Gatos, US
Eric Connor · Los Gatos, US
Randi K. GBUR · Brisbane, US
Matthew J. KADE · Berkeley, US
Paul H. KIERSTEAD · Oakland, US
Jerry M. Buysse · Los Altos, US
Michael J. Cope · Berkeley, US
Kalpesh Biyani · Fremont, US
Son H. NGUYEN · Milpitas, US
Scott M. TABAKMAN · Palo Alto, US

Key dates

Filing date	Dec 10, 2015
Grant date	Apr 26, 2022
Priority date	—
Expiry date	Oct 15, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08F226/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.